Foot reflexology to reduce nausea after sleeve gastrectomy
Impact of Foot Reflexology on Nausea After Obesity Surgery
This will try foot reflexology to see if it reduces nausea and vomiting in adults after sleeve gastrectomy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Departemental Vendee Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (La Roche-sur-Yon) |
| Trial ID | NCT07313293 on ClinicalTrials.gov |
What this trial studies
The trial delivers foot reflexology to adult patients undergoing sleeve gastrectomy and records postoperative nausea and vomiting, along with measures such as time to resume eating and length of hospital stay. Patients with foot wounds, recent foot trauma, long-term opioid use, or certain legal protection statuses are excluded. The intervention is provided in the immediate postoperative period when nausea and vomiting are most common. The study is conducted at Centre Hospitalier Départemental Vendée in La Roche-sur-Yon, France.
Who should consider this trial
Good fit: Adults scheduled for sleeve gastrectomy who can give informed consent, are affiliated with the social security system, and do not have foot injuries or long-term opioid use are ideal candidates.
Not a fit: Patients on chronic opioids, with phlebitis or recent foot trauma, pregnant or breastfeeding individuals, those under legal guardianship, or participants in conflicting protocols are unlikely to benefit.
Why it matters
Potential benefit: If successful, this could reduce postoperative nausea and vomiting and shorten hospital stay after sleeve gastrectomy.
How similar studies have performed: Some small trials of reflexology and related techniques such as acupressure have shown reductions in postoperative nausea, but evidence is mixed and larger confirmatory studies are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient * Patient scheduled to undergo sleeve gastrectomy * Patient capable of understanding the protocol and having given their informed verbal consent to participate in the study * Patient affiliated with the social security system or entitled to benefits Exclusion Criteria: * Patients receiving long-term morphine and opioid treatment * Patients with phlebitis, a wound under the foot, or recent foot trauma (cast immobilisation, splint, etc.) * Patients under guardianship, curatorship, or deprived of their liberty * Patients who are pregnant, breastfeeding, or refusing contraception * Patients participating in another clinical research protocol that has an impact on the objective of the study * Patients under an activated future protection mandate * Patients under family authorisation * Patients under judicial protection
Where this trial is running
La Roche-sur-Yon
- Centre Hospitalier Départemental Vendée — La Roche-sur-Yon, France (Recruiting)
Study contacts
- Principal investigator: Emeric ABET — Centre Hospitalier Departemental Vendee
- Study coordinator: Chloé MOREAU
- Email: chloe.moreau@ght85.fr
- Phone: 251446327
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.